On track to report data from the ongoing MYTHIC dose expansion clinical trial at the recommended Phase 2 dose (RP2D) at a company event in December...

Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The...

Results provide first evidence of biological and clinical effect of a mid-domain tau-targeting disease-modifying therapy1 In full study population...

Tokyo and Basking Ridge, NJ – (October 30, 2024) – The first patients have been dosed in three global, randomized phase 3 trials...

SAN FRANCISCO, Oct. 29, 2024. Nektar Therapeutics today announced the publication of peer-reviewed data from two Phase 1b studies in Nature...

The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after the...

Precious Manomano Herald Reporter The Malabo Declaration on Accelerated Agricultural Growth-CAADP Symposium is scheduled for November 1, 2024, in...

Competitive: ICON Strategic Solutions: The Clinical Trials Assistant (CTA) assists in the coordination and administration of the study activities...